In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
June 22nd, 2008 | 37 | No |
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.04 | 11.99 | -24.02 | 1 | 9 | 0 | 96 | 494.555 | 2 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
Target | GSK-3 | Selleck Chemicals |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CDK2-1-E | Cyclin-dependent Kinase 2 (cluster #1 Of 5), Eukaryotic | Eukaryotes | 5400 | 0.20 | Binding ≤ 10μM |
CDK4-2-E | Cyclin-dependent Kinase 4 (cluster #2 Of 3), Eukaryotic | Eukaryotes | 4800 | 0.20 | Binding ≤ 10μM |
GSK3A-1-E | Glycogen Synthase Kinase-3 Alpha (cluster #1 Of 3), Eukaryotic | Eukaryotes | 2 | 0.33 | Binding ≤ 10μM |
GSK3B-1-E | Glycogen Synthase Kinase-3 Beta (cluster #1 Of 7), Eukaryotic | Eukaryotes | 2 | 0.33 | Binding ≤ 10μM |
KPCB-1-E | Protein Kinase C Beta (cluster #1 Of 4), Eukaryotic | Eukaryotes | 560 | 0.24 | Binding ≤ 10μM |
PDK1-1-E | Pyruvate Dehydrogenase Kinase Isoform 1 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 4300 | 0.20 | Binding ≤ 10μM |
TGFR2-1-E | TGF-beta Receptor Type II (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3100 | 0.21 | Binding ≤ 10μM |
GSK3B-1-E | Glycogen Synthase Kinase-3 Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2 | 0.33 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
GSK3A_HUMAN | P49840 | Glycogen Synthase Kinase-3 Alpha, Human | 2 | 0.33 | Binding ≤ 1μM |
GSK3B_HUMAN | P49841 | Glycogen Synthase Kinase-3 Beta, Human | 2 | 0.33 | Binding ≤ 1μM |
KPCB_HUMAN | P05771 | Protein Kinase C Beta, Human | 560 | 0.24 | Binding ≤ 1μM |
CDK2_HUMAN | P24941 | Cyclin-dependent Kinase 2, Human | 5400 | 0.20 | Binding ≤ 10μM |
CDK4_HUMAN | P11802 | Cyclin-dependent Kinase 4, Human | 4800 | 0.20 | Binding ≤ 10μM |
GSK3A_HUMAN | P49840 | Glycogen Synthase Kinase-3 Alpha, Human | 2 | 0.33 | Binding ≤ 10μM |
GSK3B_HUMAN | P49841 | Glycogen Synthase Kinase-3 Beta, Human | 2 | 0.33 | Binding ≤ 10μM |
KPCB_HUMAN | P05771 | Protein Kinase C Beta, Human | 560 | 0.24 | Binding ≤ 10μM |
PDK1_HUMAN | Q15118 | Pyruvate Dehydrogenase Kinase Isoform 1, Human | 4300 | 0.20 | Binding ≤ 10μM |
TGFR2_HUMAN | P37173 | TGF-beta Receptor Type II, Human | 3100 | 0.21 | Binding ≤ 10μM |
GSK3B_HUMAN | P49841 | Glycogen Synthase Kinase-3 Beta, Human | 1.6 | 0.33 | Functional ≤ 10μM |
Description | Species |
---|---|
Activation of ATR in response to replication stress | |
Activation of NF-kappaB in B cells | |
Activation of the pre-replicative complex | |
AKT phosphorylates targets in the cytosol | |
APC truncation mutants have impaired AXIN binding | |
AXIN missense mutants destabilize the destruction complex | |
Beta-catenin phosphorylation cascade | |
CDK-mediated phosphorylation and removal of Cdc6 | |
Constitutive PI3K/AKT Signaling in Cancer | |
CRMPs in Sema3A signaling | |
Cyclin A/B1 associated events during G2/M transition | |
Cyclin A:Cdk2-associated events at S phase entry | |
Cyclin D associated events in G1 | |
Cyclin E associated events during G1/S transition | |
Degradation of beta-catenin by the destruction complex | |
Depolymerisation of the Nuclear Lamina | |
disassembly of the destruction complex and recruitment of AXIN to the membrane | |
Disinhibition of SNARE formation | |
DNA Damage/Telomere Stress Induced Senescence | |
Downregulation of TGF-beta receptor signaling | |
Factors involved in megakaryocyte development and platelet production | |
G alpha (z) signalling events | |
G0 and Early G1 | |
G2 Phase | |
Meiotic recombination | |
misspliced GSK3beta mutants stabilize beta-catenin | |
Oncogene Induced Senescence | |
Orc1 removal from chromatin | |
Oxidative Stress Induced Senescence | |
p53-Dependent G1 DNA Damage Response | |
Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 | |
Regulation of APC/C activators between G1/S and early anaphase | |
Regulation of HSF1-mediated heat shock response | |
Regulation of pyruvate dehydrogenase (PDH) complex | |
Response to elevated platelet cytosolic Ca2+ | |
RMTs methylate histone arginines | |
S33 mutants of beta-catenin aren't phosphorylated | |
S37 mutants of beta-catenin aren't phosphorylated | |
S45 mutants of beta-catenin aren't phosphorylated | |
SCF(Skp2)-mediated degradation of p27/p21 | |
Senescence-Associated Secretory Phenotype (SASP) | |
SMAD2/3 MH2 Domain Mutants in Cancer | |
SMAD2/3 Phosphorylation Motif Mutants in Cancer | |
T41 mutants of beta-catenin aren't phosphorylated | |
TGF-beta receptor signaling activates SMADs | |
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | |
TGFBR1 KD Mutants in Cancer | |
TGFBR1 LBD Mutants in Cancer | |
TGFBR2 Kinase Domain Mutants in Cancer | |
TGFBR2 MSI Frameshift Mutants in Cancer | |
Trafficking of GluR2-containing AMPA receptors | |
Transcriptional regulation of white adipocyte differentiation | |
truncations of AMER1 destabilize the destruction complex | |
Ubiquitin-dependent degradation of Cyclin D1 | |
VEGFR2 mediated cell proliferation | |
WNT5A-dependent internalization of FZD4 | |
XBP1(S) activates chaperone genes |
No pre-computed analogs available. Try a structural similarity search.